Inhibition of ERK1/2 or CRMP2 Disrupts Alcohol Memory Reconsolidation and Prevents Relapse in Rats

Nofar Rahamim,Mirit Liran,Coral Aronovici,Hila Flumin,Tamar Gordon,Nataly Urshansky,Segev Barak
DOI: https://doi.org/10.3390/ijms25105478
IF: 5.6
2024-05-18
International Journal of Molecular Sciences
Abstract:Relapse to alcohol abuse, often caused by cue-induced alcohol craving, is a major challenge in alcohol addiction treatment. Therefore, disrupting the cue-alcohol memories can suppress relapse. Upon retrieval, memories transiently destabilize before they reconsolidate in a process that requires protein synthesis. Evidence suggests that the mammalian target of rapamycin complex 1 (mTORC1), governing the translation of a subset of dendritic proteins, is crucial for memory reconsolidation. Here, we explored the involvement of two regulatory pathways of mTORC1, phosphoinositide 3-kinase (PI3K)-AKT and extracellular regulated kinase 1/2 (ERK1/2), in the reconsolidation process in a rat (Wistar) model of alcohol self-administration. We found that retrieval of alcohol memories using an odor-taste cue increased ERK1/2 activation in the amygdala, while the PI3K-AKT pathway remained unaffected. Importantly, ERK1/2 inhibition after alcohol memory retrieval impaired alcohol-memory reconsolidation and led to long-lasting relapse suppression. Attenuation of relapse was also induced by post-retrieval administration of lacosamide, an inhibitor of collapsin response mediator protein-2 (CRMP2)—a translational product of mTORC1. Together, our findings indicate the crucial role of ERK1/2 and CRMP2 in the reconsolidation of alcohol memories, with their inhibition as potential treatment targets for relapse prevention.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper primarily explores the possibility of disrupting the reconsolidation process of alcohol memories by inhibiting ERK1/2 or CRMP2, and preventing alcohol relapse in rats. The core issue of the paper is the problem of relapse in alcohol addiction treatment, particularly relapse triggered by strong cravings induced by alcohol-related cues. The authors propose that if these alcohol-related memories can be interfered with, relapse behavior can be effectively suppressed. The study found that when memories are recalled, they temporarily become unstable and then restabilize during the reconsolidation process, which requires protein synthesis. Based on the above background, researchers explored the roles of two signaling pathways regulating mTORC1 (mammalian target of rapamycin complex 1)—PI3K-AKT and ERK1/2—in the reconsolidation process of alcohol memories in a rat model. The study results indicate: 1. **PI3K-AKT signaling pathway**: The retrieval of alcohol memories did not activate the phosphorylation levels of key proteins (AKT, GSK3β, and CRMP2) in the PI3K-AKT signaling pathway, suggesting that this pathway may not be involved in the reconsolidation process of alcohol memories. 2. **Role of CRMP2**: Although no changes in the phosphorylation levels of CRMP2 were observed, the use of the CRMP2 inhibitor lacosamide reduced alcohol consumption in rats, suggesting that CRMP2 plays a role in the reconsolidation of alcohol memories. 3. **Role of GSK3β**: Inhibiting GSK3β did not affect alcohol relapse behavior in rats, which is different from the results observed with CRMP2. 4. **Role of ERK1/2**: After the retrieval of alcohol memories, the phosphorylation levels of ERK1/2 in the amygdala significantly increased, suggesting that ERK1/2 may be involved in the reconsolidation process of alcohol memories. The use of the ERK1/2 inhibitor SL-327 significantly reduced alcohol consumption in rats, and this effect persisted. In summary, the study reveals the critical roles of ERK1/2 and CRMP2 in the reconsolidation process of alcohol memories and proposes potential therapeutic strategies to prevent alcohol relapse by inhibiting these molecules.